CRBP
Corbus Pharmaceuticals Holding
7.50$
-3.7%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | – | – | – | 100.0% | – | – | – | – | – | – | – | |
| – | 11.0% | – | – | – | 20.8% | – | – | – | – | – | – | – | |
| – | -11.0% | – | – | – | -20.8% | – | – | – | – | – | – | – | |
| – | 517.1% | – | – | – | 1,249.3% | – | – | – | – | – | – | – | |
| – | 231.4% | – | – | – | 542.8% | – | – | – | – | – | – | – | |
| – | 737.6% | – | – | – | 1,771.3% | – | – | – | – | – | – | – | |
| – | -748.5% | – | – | – | -1,792.1% | – | – | – | – | – | – | – | |
| – | 52.4% | – | – | – | 94.1% | – | – | – | – | – | – | – | |
| – | -594.3% | – | – | – | -1,354.9% | – | – | – | – | – | – | – | |
| – | 0.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -594.3% | – | – | – | -1,354.9% | – | – | – | – | – | – | – | |
| – | -530.9% | – | – | – | -1,334.1% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.